Decades of research have taught us a lot about why people get cancer. The mystery is why, even when they have multiple risk factors, some people don’t.  If we can […]

Glioblastoma patients have been left in limbo, with drug development stalled due to a combination of complex biology, a fearsomely aggressive disease and a risk-averse pharma industry. But momentum in […]

Have you published a paper in the past three years that could have, or is already having, a major 3Rs impact?  We award the International 3Rs Prize each year to recognise a […]

Canadian researchers have developed a more effective and longer-lasting treatment for glaucoma eye disease, in a study with rats. Glaucoma – 10% of all blindness worldwide – damages the optic […]

Researchers at the Francis Crick Institute have shown that water influx is necessary for immune cells called T cells to activate and divide in response to a threat.  T cells […]

In a historic decision, the US FDA (Food and Drug Administration) has approved the first clinical trial of its kind, testing whether pig organs can be safely implanted into humans. […]